|Day Low/High||77.62 / 78.67|
|52 Wk Low/High||56.81 / 77.33|
Keeping an eye on the Senate shutdown vote and any trade discussion today, and watching key support levels on the SPX.
The kick will come from the Chinese capitulating because their economy is so weak.
Mike Cintolo and Jim Woods saw their top picks for 2018 rise 81% and 75%, respectively.
Take upbeat outlooks for equities with a grain of salt, and try these sectors to stay safe.
Pfizer trades with a trailing PE of 15 and is expected to grow earnings 2% in 2019.
It becomes difficult for me to tell you where to run in these markets...
I am unimpressed by the latest earnings report. Despite good subscriber growth, fundamentals look weak.
While Abbott's charts are not screaming sells, there are enough signals to suggest a cautious approach to earnings.
PepsiCo, GE and just like the weather, the stock market is subject to change.
Straying from these names could land you in quicksand as the 4th quarter begins.
Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.
It is all about perception, and here are strong names to pick up on market weakness.
As hedge funds are forced to unwind tech positions, here is how to play the rotation.
Earnings have been strong, and analysts will soon start to concentrate more on actual weakness than shadow-boxing weakness.
If you are long ABT continue to hold and raise sell stop protection to a close below $59 or where the 200-day moving average line intersects.
This group is expected to post second-quarter EPS gains of 30%; here is how to trade it.
When chartists look for the next market leaders they often go to stocks that have held up the best during corrections.
When rates decline, most of the S&P 500 benefits, according to TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.
The crash of oil will only accelerate the move.
Market reactions have ranged anywhere from lackluster to outright negative. What gives?
Sectors are saying different things about rates, but new Fed chief Jerome Powell could provide clarity at his first press conference on Wednesday.
TheStreet's founder Jim Cramer and a panel of top experts discuss how investors should be positioning their portfolio for March in this month's Trading Strategies session. In this clip above, listen to them discuss healthcare stocks and why they think they're too hard to trade.
ABT has been in a strong and durable uptrend and that is likely to continue.
Don't worry about missing anything, we haven't solved the bond conundrum and the evidence says we get to 3% with selloffs on the way.
John Flannery sees progress being made on GE's initiatives, but that is what I expected him to say.